Terms: = Endocrine gland cancer AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1 AND Prognosis
45 results:
1. Network Pharmacological Analysis and Experimental Validation of the Effects of Silybin on Proliferation, Migration, and Immunotherapy of Papillary Thyroid cancer.
Xie W; Li H; Lin Q; Ke N
Endocr Metab Immune Disord Drug Targets; 2024; 24(6):672-690. PubMed ID: 37855349
[TBL] [Abstract] [Full Text] [Related]
2. Construction of a ferroptosis-related eight gene signature for predicting the prognosis and immune infiltration of thyroid cancer.
Ren X; Du H; Cheng W; Wang Y; Xu Y; Yan S; Gao Y
Front Endocrinol (Lausanne); 2022; 13():997873. PubMed ID: 36407322
[TBL] [Abstract] [Full Text] [Related]
3. Identifying key genes of classic papillary thyroid cancer in women aged more than 55 years old using bioinformatics analysis.
Li CC; Ullah MHE; Lin X; Shan SK; Guo B; Zheng MH; Wang Y; Li F; Yuan LQ
Front Endocrinol (Lausanne); 2022; 13():948285. PubMed ID: 36120433
[TBL] [Abstract] [Full Text] [Related]
4. timp1 derived from pancreatic cancer cells stimulates Schwann cells and promotes the occurrence of perineural invasion.
Tian Z; Ou G; Su M; Li R; Pan L; Lin X; Zou J; Chen S; Li Y; Huang K; Chen Y
Cancer Lett; 2022 Oct; 546():215863. PubMed ID: 35961511
[TBL] [Abstract] [Full Text] [Related]
5. timp1 Triggers Neutrophil Extracellular Trap Formation in Pancreatic cancer.
Schoeps B; Eckfeld C; Prokopchuk O; Böttcher J; Häußler D; Steiger K; Demir IE; Knolle P; Soehnlein O; Jenne DE; Hermann CD; Krüger A
Cancer Res; 2021 Jul; 81(13):3568-3579. PubMed ID: 33941611
[TBL] [Abstract] [Full Text] [Related]
6. A novel tissue inhibitor of metalloproteinases-1/liver/cachexia score predicts prognosis of gastrointestinal cancer patients.
Prokopchuk O; Hermann CD; Schoeps B; Nitsche U; Prokopchuk OL; Knolle P; Friess H; Martignoni ME; Krüger A
J Cachexia Sarcopenia Muscle; 2021 Apr; 12(2):378-392. PubMed ID: 33590974
[TBL] [Abstract] [Full Text] [Related]
7. Circulating Tumor Cells Characterization Revealed timp1 as a Potential Therapeutic Target in Ovarian cancer.
Abreu M; Cabezas-Sainz P; Alonso-Alconada L; Ferreirós A; Mondelo-Macía P; Lago-Lestón RM; Abalo A; Díaz E; Palacios-Zambrano S; Rojo-Sebastian A; López-López R; Sánchez L; Moreno-Bueno G; Muinelo-Romay L
Cells; 2020 May; 9(5):. PubMed ID: 32423054
[TBL] [Abstract] [Full Text] [Related]
8. Novel scoring system for recurrence risk classification of surgically resected G1/2 pancreatic neuroendocrine tumors - Retrospective cohort study.
Zou S; Jiang Y; Wang W; Zhan Q; Deng X; Shen B
Int J Surg; 2020 Feb; 74():86-91. PubMed ID: 31926324
[TBL] [Abstract] [Full Text] [Related]
9. Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma.
Yu S; Li Y; Liao Z; Wang Z; Wang Z; Li Y; Qian L; Zhao J; Zong H; Kang B; Zou WB; Chen K; He X; Meng Z; Chen Z; Huang S; Wang P
Gut; 2020 Mar; 69(3):540-550. PubMed ID: 31562239
[TBL] [Abstract] [Full Text] [Related]
10. Key genes associated with pancreatic cancer and their association with outcomes: A bioinformatics analysis.
Wu J; Li Z; Zeng K; Wu K; Xu D; Zhou J; Xu L
Mol Med Rep; 2019 Aug; 20(2):1343-1352. PubMed ID: 31173193
[TBL] [Abstract] [Full Text] [Related]
11. Expressions of Matrix Metalloproteinases-9 and Tissue Inhibitor of Metalloproteinase-1 in Pituitary Adenomas and Their Relationships with prognosis.
Guo H; Sun Z; Wei J; Xiang Y; Qiu L; Guo L; Zhao W; Xu Z; Mao J
Cancer Biother Radiopharm; 2019 Feb; 34(1):1-6. PubMed ID: 30676069
[TBL] [Abstract] [Full Text] [Related]
12. Identification of key genes and miRNAs markers of papillary thyroid cancer.
Qiu J; Zhang W; Zang C; Liu X; Liu F; Ge R; Sun Y; Xia Q
Biol Res; 2018 Nov; 51(1):45. PubMed ID: 30414611
[TBL] [Abstract] [Full Text] [Related]
13. Identification of Candidate Genes Associated with Chemotherapy Resistance in Ovarian cancer.
Zhang B; Wang L; Zhao X; Wei Y; Zhang Y
Ann Clin Lab Sci; 2018 Sep; 48(5):573-579. PubMed ID: 30373860
[TBL] [Abstract] [Full Text] [Related]
14. Gene expression differences between thyroid carcinoma, thyroid adenoma and normal thyroid tissue.
Wang Q; Shen Y; Ye B; Hu H; Fan C; Wang T; Zheng Y; Lv J; Ma Y; Xiang M
Oncol Rep; 2018 Dec; 40(6):3359-3369. PubMed ID: 30272326
[TBL] [Abstract] [Full Text] [Related]
15. FH535, a β-catenin pathway inhibitor, represses pancreatic cancer xenograft growth and angiogenesis.
Liu L; Zhi Q; Shen M; Gong FR; Zhou BP; Lian L; Shen B; Chen K; Duan W; Wu MY; Tao M; Li W
Oncotarget; 2016 Jul; 7(30):47145-47162. PubMed ID: 27323403
[TBL] [Abstract] [Full Text] [Related]
16. New potential chemotherapy for ovarian cancer - Combined therapy with WP 631 and epothilone B.
Bukowska B; Rogalska A; Marczak A
Life Sci; 2016 Apr; 151():86-92. PubMed ID: 26944437
[TBL] [Abstract] [Full Text] [Related]
17. Targeting pancreatic cancer using a combination of gemcitabine with the omega-3 polyunsaturated fatty acid emulsion, Lipidem™.
Haqq J; Howells LM; Garcea G; Dennison AR
Mol Nutr Food Res; 2016 Jun; 60(6):1437-47. PubMed ID: 26603273
[TBL] [Abstract] [Full Text] [Related]
18. Identification of ANXA1 as a lymphatic metastasis and poor prognostic factor in pancreatic ductal adenocarcinoma.
Liu QH; Shi ML; Bai J; Zheng JN
Asian Pac J Cancer Prev; 2015; 16(7):2719-24. PubMed ID: 25854353
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic significance of timp-2, MMP-2, and MMP-9 on high-grade serous ovarian carcinoma using digital image analysis.
Desmeules P; Trudel D; Turcotte S; Sirois J; Plante M; Grégoire J; Renaud MC; Orain M; Têtu B; Bairati I
Hum Pathol; 2015 May; 46(5):739-45. PubMed ID: 25771900
[TBL] [Abstract] [Full Text] [Related]
20. [Clinical prospects of tumor-associated proteases and their tissue inhibitors investigation in oncologic patient].
Gershteĭn ES; Kushlinskiĭ NE
Vestn Ross Akad Med Nauk; 2013; (5):16-27. PubMed ID: 24000664
[TBL] [Abstract] [Full Text] [Related]
[Next]